Melatonin Time Release 5 mg Fabricants_Atrantil symptomatic control of estrogen-dominated health

symptomatic control of estrogen-dominated health conditions

GI models and in vitro studies reveal that only 6-8% of SunButyrate™ degrades

Contains no artificial colors

Provides comprehensive nutritional support

Melatonin Time Release 5 mg Fabricants_Atrantil symptomatic control of estrogen-dominated healthClinically proven improvement in sleep quality, morning alertness, sleep onset latency, and quality of life. Supplementation is linked to improved mood and cognitive function in people with sleep disorders. Each tablet contains 5 mg of delayed release melatonin. The timed release formulation maintains plasma levels for a longer period, improving sleep initiation, maintenance, and quality. Non habit forming Sleep is an essential component of health,